Kostas Alevizopoulos
InvestorPartner at Ventac Partners
Switzerland
Writes $100K – $5M checks · typically $1.5M
About
Kostas Alevizopoulos is Chief Executive Officer at APIM Therapeutics. He brings more than 25 years of experience in biotechnology, pharmaceuticals, diagnostics, medical devices, and consumer healthcare, with expertise spanning product development, technology transfer, intellectual property, licensing, fundraising, and commercialization. His career includes management of international R&D and business activities across Europe, North America, and Asia-Pacific, involvement with over 150 CROs, CMOs, and academic partners, and authorship of 40+ peer-reviewed publications and multiple patent families.
Experience
- APIM TherapeuticsChief Executive Officercurrent2010 — presentNorway
- Gerolymatos InternationalChief Scientific Advisorcurrent2010 — presentSwitzerland & Greece
- AlterbiotixCo-Foundercurrent2025 — present
- Ventac PartnersPartnercurrent2007 — presentSwitzerland
- Exogenus TherapeuticsStrategic Advisor2021 — 2024Portugal
- Coegin Pharma ABHead of Preclinical R&D2012 — 2021Sweden
- ZestagenChairman of the Scientific Advisory Board2012 — 2016Switzerland
- PharmacellionDirector2012 — 2016United Kingdom
- FOLTENE LABORATORIES SRLScientific Advisor2015Italy
- Ministry of Development and Hellenic Industry Federation (Project DETEP-PRAXI)Industry Consultant2011 — 2015Greece
- Hellenic Biotechnology ClusterVice President & Board Member2007 — 2014Greece
- MedexisChief Executive Officer2002 — 2010Greece
- Gerolymatos GroupChief Scientific Officer2006 — 2008Greece
- Apotech CorporationHead of R & D2000 — 2002Switzerland
- Swiss Inst. for Cancer Res. & Schering-Plough Res. InstituteResearch Project Manager1999 — 2001Switzerland & USA
Education
- University of Lausanne - UNILPh.D., Molecular Biology1994 — 1998
- Ethnikon kai Kapodistriakon Panepistimion AthinonDiploma in Biochemistry, Biology1989 — 1993
Skills & more
+12 more
GenomicsDrug DiscoveryPatentsImmunologyR&DIP managementBiopharmaceuticalsPharmaceuticsDrug & Medical Device DevelopmentIn-licensing & Technology TransferDrug ProductCROLanguages English · French · German · Greek · Spanish
From Kostas's professional profile.
Colleagues at Ventac Partners
Network4
Investors connected to Kostas in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Kostas Alevizopoulos work?
- Kostas Alevizopoulos is Partner at Ventac Partners.
- What check size does Kostas Alevizopoulos write?
- Kostas Alevizopoulos typically writes checks of $100K – $5M.
Same school
Also attended University of Lausanne - UNIL13
+ 7 more
Also attended Ethnikon kai Kapodistriakon Panepistimion Athinon11
+ 5 more
